Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis
- PMID: 23053396
- PMCID: PMC4111229
- DOI: 10.1007/s00281-012-0350-8
Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis
Abstract
The outcomes of Leishmania infection are determined by host immune and nutrition status, parasite species, and co-infection with other pathogens. While subclinical infection and self-healing cutaneous leishmaniasis (CL) are common, uncontrolled parasite replication can lead to non-healing local lesions or visceral leishmaniasis (VL). It is known that infection control requires Th1-differentiation cytokines (IL-12, IL-18, and IL-27) and Th1 cell and macrophage activation. However, there is no generalized consensus for the mechanisms of host susceptibility. The recent studies on regulatory T cells and IL-17-producing cells help explain the effector T cell responses that occur independently of the known Th1/Th2 cell signaling pathways. This review focuses on the immunopathogenesis of non-healing American CL and progressive VL. We summarize recent evidence from human and animal studies that reveals the mechanisms of dysregulated, hyper-responses to Leishmania braziliensis, as well as the presence of disease-promoting or the absence of protective responses to Leishmania amazonensis and Leishmania donovani. We highlight immune-mediated parasite growth and immunopathogenesis, with an emphasis on the putative roles of IL-17 and its related cytokines as well as arginase. A better understanding of the quality and regulation of innate immunity and T cell responses triggered by Leishmania will aid in the rational control of pathology and the infection.
Figures
Similar articles
-
Cytokines in the immunity and immunopathogenesis in leishmaniases.Cytokine. 2021 Sep;145:155320. doi: 10.1016/j.cyto.2020.155320. Epub 2020 Oct 27. Cytokine. 2021. PMID: 33127260 Review.
-
The Paradox of a Phagosomal Lifestyle: How Innate Host Cell-Leishmania amazonensis Interactions Lead to a Progressive Chronic Disease.Front Immunol. 2021 Sep 7;12:728848. doi: 10.3389/fimmu.2021.728848. eCollection 2021. Front Immunol. 2021. PMID: 34557194 Free PMC article. Review.
-
Immunopathogenesis of infection with the visceralizing Leishmania species.Microb Pathog. 2005 Apr;38(4):147-60. doi: 10.1016/j.micpath.2004.11.002. Microb Pathog. 2005. PMID: 15797810 Review.
-
Cytokine-producing T cell subsets in human leishmaniasis.Arch Immunol Ther Exp (Warsz). 2000;48(3):173-6. Arch Immunol Ther Exp (Warsz). 2000. PMID: 10912621 Review.
-
The importance of T cell-derived cytokines in post-kala-azar dermal leishmaniasis.Cytokine. 2021 Nov;147:155321. doi: 10.1016/j.cyto.2020.155321. Epub 2020 Oct 8. Cytokine. 2021. PMID: 33039255 Review.
Cited by
-
Immunotherapeutic Strategies as Potential Treatment Options for Cutaneous Leishmaniasis.Vaccines (Basel). 2024 Oct 17;12(10):1179. doi: 10.3390/vaccines12101179. Vaccines (Basel). 2024. PMID: 39460345 Free PMC article. Review.
-
Malnutrition-related parasite dissemination from the skin in visceral leishmaniasis is driven by PGE2-mediated amplification of CCR7-related trafficking of infected inflammatory monocytes.PLoS Negl Trop Dis. 2023 Jan 11;17(1):e0011040. doi: 10.1371/journal.pntd.0011040. eCollection 2023 Jan. PLoS Negl Trop Dis. 2023. PMID: 36630476 Free PMC article.
-
Temporary Shutdown of ERK1/2 Phosphorylation Is Associated With Activation of Adaptive Immune Cell Responses and Disease Progression During Leishmania amazonensis Infection in BALB/c Mice.Front Immunol. 2022 Jan 25;13:762080. doi: 10.3389/fimmu.2022.762080. eCollection 2022. Front Immunol. 2022. PMID: 35145518 Free PMC article.
-
Revival of Leishmanization and Leishmanin.Front Cell Infect Microbiol. 2021 Mar 17;11:639801. doi: 10.3389/fcimb.2021.639801. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 33816344 Free PMC article. Review.
-
Tryp-ing Up Metabolism: Role of Metabolic Adaptations in Kinetoplastid Disease Pathogenesis.Infect Immun. 2021 Mar 17;89(4):e00644-20. doi: 10.1128/IAI.00644-20. Print 2021 Mar 17. Infect Immun. 2021. PMID: 33526564 Free PMC article. Review.
References
-
- Banuls AL, Hide M, Prugnolle F. Leishmania and the leishmaniases: a parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans. Adv Parasitol. 2007;64:1–109. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous